Finland· FI-REL-REL5446
Myocrisin
A sodium aurothiomalate product, registered in Finland by May & Baker Limited. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Sodium aurothiomalate is registered in 2 of 19 countries.
Countries holding a registration under ATC M01CB01 (sodium aurothiomalate), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Sodium aurothiomalate · ATC M01CB01
2 / 19 countries
- Finlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Manufacturer
- May & Baker Limited
- Country
- Finland (FI)
- ATC code
- M01CB01
- ATC class
- Sodium aurothiomalate
- Defined daily dose
- 2.4 mg, P
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for sodium aurothiomalate.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium aurothiomalate · interactions on record
85 records
- 16 severe
- 69 moderate
Most severe, free to view
- CladribineL01BB04severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- CladribineL04AA40severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M01CB01
Sodium aurothiomalate, as other registers publish it.
- FinlandMyocrisinMay & Baker Limited
- FinlandMyocrisinMay & Baker Limited
- FinlandMyocrisinsanofi-Aventis Oy
- FinlandMyocrisinSanofi Oy
- FinlandMyocrisinSanofi Oy
- United KingdomMyocrisin 10mg/0.5ml solution for injection ampoulesSanofi
- United KingdomMyocrisin 20mg/0.5ml solution for injection ampoulesSanofi
- United KingdomMyocrisin 50mg/0.5ml solution for injection ampoulesSanofi
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8170a1fd-c8d5-4d06-bdae-ccc65e62f4b0 GET /v1/drugs/8170a1fd-c8d5-4d06-bdae-ccc65e62f4b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2.4",
"form": "injektioneste",
"route": null,
"ddd_unit": "mg",
"strength": "100 mg/ml",
"atc_label": "natriumaurotiomalaatti",
"ma_number": "4872",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL5446",
"authorised_at": "1967-08-23"
}See everything about sodium aurothiomalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.